2 completed, 1 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Withdrawn 1 |
Follow Jaundice, Obstructive: new trials by email Literature Review of Jaundice, Obstructive trials Research Report on Jaundice, Obstructive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remaxol® in Mechanical Jaundice of Non-malignant Origin Remaxol (succinate + methionine + inosine + nicotinamide), Ringer's Solution - Jaundice, Obstructive | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 342 | 2017-04-03 | 2020-07-14 |
| Remaxol® in Malignant Mechanical Jaundice Remaxol®, Ringer's Solution - Jaundice; Malignant | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 240 | 2017-04-03 | 2020-07-10 |
| Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction parallel stent, Y-stent (BONASTENT M-Hilar) - Bile Duct Neoplasm, Obstructive Jaundice | Phase 3 | Withdrawn | Samsung Medical Center | 2011-08-01 | 2016-04-26 |
Bile Duct Neoplasms (1) · Jaundice (1)
Hyperbilirubinemia (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Skin Manifestations (3) · Jaundice (2) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Biliary Tract Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1)
Inosine (2) · Methionine (2) · Niacinamide (2) · Remaxol (2) · Ringer's Solution (2) · Succinic Acid (2)
POLYSAN Scientific & Technological Pharmaceutical Company (2) · Samsung Medical Center (1)
Russia (2) · South Korea (1)